Who is going to benefit from nystatin prophylaxis for fungal peritonitis complicating CAPD?
Lo
W K
WK
Cheng
I K
IK
D000935:Antifungal Agents / Q000627:therapeutic use*; D006801:Humans; D009181:Mycoses / Q000209:etiology / Q000517:prevention & control*; D009761:Nystatin / Q000627:therapeutic use*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control*
D000935:Antifungal Agents; D009761:Nystatin